“Love Hormone” Oxytocin Could Be Used to Treat Cognitive Disorders Like Alzheimer’s
Scientists discover for the first time that oxytocin could be a potential new therapeutic option for cognitive disorders such as Alzheimer’s disease
Alzheimer’s disease progressively degrades a person’s memory and cognitive abilities, often resulting in dementia. Amid efforts to find novel treatments for this disease, a recent breakthrough study by scientists from Japan shows that oxytocin?the hormone that we commonly know to induce feelings of love and well-being?can also effectively reverse some of the damage caused by amyloid plaques in the learning and memory center of the brain in an animal model of Alzheimer’s.
Alzheimer’s disease is a progressive disorder in which the nerve cells (neurons) in a person’s brain and the connections among them degenerate slowly, causing severe memory loss, intellectual deficiencies, and deterioration in motor skills and communication. One of the main causes of Alzheimer’s is the accumulation of a protein called amyloid ? (A?) in clusters around neurons in the brain, which hampers their activity and triggers their degeneration. Studies in animal models have found that increasing the aggregation of A? in the hippocampus?the brain’s main learning and memory center?causes a decline in the signal transmission potential of the neurons therein. This degeneration affects a specific trait of the neurons, called “synaptic plasticity,” which is the ability of synapses (the site of signal exchange between neurons) to adapt to an increase or decrease in signaling activity over time. Synaptic plasticity is crucial to the development of learning and cognitive functions in the hippocampus. Thus, A? and its role in causing cognitive memory and deficits have been the focus of most research aimed at finding treatments for Alzheimer’s.
Now, advancing this research effort, a team of scientists from Japan, led by Professor Akiyoshi Saitoh from the Tokyo University of Science, has looked at oxytocin, a hormone conventionally known for its role in the female reproductive system and in inducing the feelings of love and well-being. “Oxytocin was recently found to be involved in regulating learning and memory performance, but so far, no previous study deals with the effect of oxytocin on A?-induced cognitive impairment,” Prof Saitoh says. Realizing this, Prof Saitoh’s group set out to connect the dots.
Their findings are published in Biochemical and Biophysical Research Communication.
Prof Saitoh and team first perfused slices of the mouse hippocampus with A? to confirm that A? causes the signaling abilities of neurons in the slices to decline or?in other words?impairs their synaptic plasticity. Upon additional perfusion with oxytocin, however, the signaling abilities increased, suggesting that oxytocin can reverse the impairment of synaptic plasticity that A? causes.
To find out how oxytocin achieves this, they conducted a further series of experiments. In a normal brain, oxytocin acts by binding with special structures in the membranes of brain cells, called oxytocin receptors. The scientists artificially “blocked” these receptors in the mouse hippocampus slices to see if oxytocin could reverse A??induced impairment of synaptic plasticity without binding to these receptors. Expectedly, when the receptors were blocked, oxytocin could not reverse the effect of A?, which shows that these receptors are essential for oxytocin to act.
Oxytocin is known to facilitate certain cellular chemical activities that are important in strengthening neuronal signaling potential and formation of memories, such as influx of calcium ions. Previous studies have suspected that A? suppresses some of these chemical activities. When the scientists artificially blocked these chemical activities, they found that addition of oxytocin addition to the hippocampal slices did not reverse the damage to synaptic plasticity caused by A?. Additionally, they found that oxytocin itself does not have any effect on synaptic plasticity in the hippocampus, but it is somehow able to reverse the ill?effects of A?.
Prof Saitoh remarks, “This is the first study in the world that has shown that oxytocin can reverse A?-induced impairments in the mouse hippocampus.” This is only a first step and further research remains to be conducted in vivo in animal models and then humans before sufficient knowledge can be gathered to reposition oxytocin into a drug for Alzheimer’s. But, Prof Saitoh remains hopeful. He concludes, “At present, there are no sufficiently satisfactory drugs to treat dementia, and new therapies with novel mechanisms of action are desired. Our study puts forth the interesting possibility that oxytocin could be a novel therapeutic modality for the treatment of memory loss associated with cognitive disorders such as Alzheimer’s disease. We expect that our findings will open up a new pathway to the creation of new drugs for the treatment of dementia caused by Alzheimer’s disease.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- The Mind-Changing Power of Petson July 22, 2021 at 8:37 am
I’d had pets before. My parents took me to adopt my first dog when I was nine. So as an only child, I still had playful company around, even if it meant throwing a Frisbee to a bug-eyed Chihuahua, ...
- The Global Oxytocin Market is projected to reach US$ nearly US$ 165 Mn by 2030on July 22, 2021 at 4:41 am
ESOMAR certified consulting firm Future Market Insights (FMI) has recently published an exhaustive yet unbiased report on the global oxytocin market, highlighting the prominent parameters responsible ...
- Bold and complex: 'Oxytocin' wins Dayton Playhouse FutureFest of new playson July 19, 2021 at 6:11 pm
Clayton, Missouri playwright Cary Simowitz's bold, complex, vibrant, and thought-provoking coming-of-age dramedy "All the Oxytocin in Your Fingertips" received top honors at the Dayton Playhouse ...
- Bold and complex: ‘Oxytocin’ wins Dayton Playhouse FutureFest of new playson July 18, 2021 at 5:00 pm
“I’m just so grateful to everyone at the Dayton Playhouse for taking a chance on a theatrically complicated, risky play,” playwright Cary Simowitz said. Clayton, Missouri playwright Cary ...
- Editorial: Allegations of racism and poor medical care during childbirthon July 16, 2021 at 9:27 pm
White’s doctor ordered the drug oxytocin to be administered every 30 minutes as soon as the baby was in the correct position. Oxytocin causes contractions, and is administered in increasing ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Therapeutic options for cognitive disorders
- ZoomCare Expands Mental Health Offering With Launch of Virtual Therapyon July 20, 2021 at 8:06 am
ZoomCare, the Pacific Northwest-based innovator and creator of on-demand healthcare, now offers Mental Health Therapy as a part of its comprehensive mental health offerings for Oregon residents.
- Ninilchik Village Tribe Will Provide Access to Prescription Digital Therapeutics to Help Alaskan Community Treat Rural Patients with Substance and Opioid Use Disorderson July 20, 2021 at 5:30 am
Ninilchik Village Tribe Will Provide Access to Prescription Digital Therapeutics to Help Alaskan Community Treat Rural Patients with SUD and OUD ...
- Addressing the Cognition Crisis in Our COVID-19 Worldon July 19, 2021 at 8:00 am
The world is facing a cognition crisis. Here’s how to face it with measurement-based cognitive care. The world is in the midst of an unfolding cognition crisis, with devastating personal, societal, ...
- The Different Types of Therapy (and How They Work)on July 12, 2021 at 10:00 pm
Yes, there are a lot of different types of therapy, but the distinctions are less rigid than you might think, a ...
- Useful strategies can help alleviate mental health problems during the pandemicon July 11, 2021 at 10:56 pm
In spite of many clinical options, people with mental health problems including eating disorders often do not access professional help within the crucial first 12 months – in part because of lack of ...